共 2 条
- [2] Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial (vol 9, pg 1299, 2021) LANCET RESPIRATORY MEDICINE, 2021, 9 (11): : E106 - E106